4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001628280-22-030946
Chief Executive Officer bought 10,000 shares at $1.43 ($14,300)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Erlander Mark Chief Executive Officer | 2022-11-25 | Purchase | +10,000 | $1.43 | $14,300 | 24,481 | D |
| Open-market purchases · 10,000 sh · avg $1.43 · $14,300 | |||||||
Loading xslF345X03/wf-form4_166975625707899.xml…